(S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide: Reliable Quality from a Trusted Chemical Manufacturer

Commitment to Purity Begins in the Lab

Over the past two decades, we've watched the market for advanced fine chemicals shift from a small, niche segment to one marked by rapid innovation. Through every stage, the biggest value we’ve delivered comes down to process reliability and product consistency. Among the new generation of chiral building blocks, (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide stands out as a practical choice for chemists aiming for clear results—especially in medicinal chemistry and pharmaceutical development.

We learned early on that researchers demand more than specification sheets and purity numbers. Batch-to-batch uniformity, handleability in the lab, trace-level impurity control—these make the real difference in hands-on work. Our facility’s workflow links synthesis, purification, and final packaging in a single controlled chain to keep each unit of (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide at or above the 98% enantiomeric excess mark, with HPLC, NMR, and moisture content checks integrated into every batch release.

Building the Molecule, Building Trust

Our team sources raw materials directly after verification with multi-stage ID testing. After a series of clean-room syntheses and crystallizations, the hydrobromide salt is separated, washed, and dried with minimal exposure to air. Managing humidity in the step after crystallization lowers the risk of hydrolysis, which can otherwise introduce trace decomposition products noticeable in reaction optimization studies.

This dedication comes from our own earliest days in the lab—when a minor impurity in a purchased chiral intermediate caused an entire project to fall flat. Since then, we take every effort to ensure full traceability of each kilogram we ship. Each bottle leaves with supporting documentation and a full batch history available upon request, fostering reproducibility in downstream processes.

Supporting Stereochemistry in Advanced Synthesis

Many compounds offer almost-identical skeletal frameworks—in the case of amino-gamma-butyrolactones, it’s the stereochemistry that determines whether a given molecule will fit or disrupt a target receptor. The S enantiomer, found here as (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide, allows for tighter control in asymmetric syntheses. Our route favors this S configuration, minimizing unwanted racemization.

Chemists often debate the best source of stereospecific building blocks. Our practical experience has shown that controlling temperature and reaction time during the ring closure prevents racemization, which can otherwise force repeated reprocessing and loss of valuable product. It takes more time upfront, but cutting corners here only shifts work—and costs—to the later stages, which isn’t tenable when benchmarking for clinical candidates.

Why Form as the Hydrobromide Salt?

Some users ask why we offer this compound as the hydrobromide salt and not just the free base. Our choice arises directly from stability studies. The hydrobromide form resists oxidative breakdown and atmospheric moisture much better on the bench. Handling and storage become straightforward, particularly in climates where humidity or heat make the free base less reliable. This extends real-world shelf-life and preserves optical purity—critical if you’re pulling the compound for use in protracted research campaigns.

Through direct feedback from companies in both North America and Europe, we found shelf-stable stocks reduce unplanned downtime, especially when projects run months longer than anticipated. The hydrobromide salt maintains its crystalline character, pours easily, and dissolves quickly in common laboratory solvents.

Where (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide Succeeds in Use

Looking at the projects our product has supported, medicinal chemistry leads the way. Researchers working on GABA analogues or β-lactam intermediates come back to this compound for its efficiency as a chiral synthon. In our own collaborations, we’ve seen it streamline steps in the synthesis of both CNS-active drugs and enzyme inhibitors.

Beyond pharma, the built-in chirality serves well in research on new materials and specialty polymers. The defined S configuration translates to predictable outcomes downstream, which reduces reruns and troubleshooting. Laboratories tackling enantioselective hydrogenations or aiming for asymmetric ring openings can rely on the consistent chiral purity our production process provides.

Another important advantage shows up in custom synthesis and scale-up. Process chemists often must optimize reaction conditions using small, well-characterized lots before launching into larger batches. Making sure every gram behaves the same, regardless of run size, protects the results obtained in discovery phases and lets teams transition more smoothly to kilo-scale and beyond.

Comparison Against Similar Offerings

Consumers sometimes compare this compound to the racemate or the R enantiomer. The cost of producing a single-enantiomer product remains higher—enantiomeric separation, process control, and specialized purification demand more input at every stage. Our difference lies in holding strict chiral and chemical purity, rejecting any lot that shows cross-contamination or enantiomeric drift.

Suppliers may offer racemic α-amino-γ-butyrolactone at a lower price, but purification downstream nearly always returns higher labor and yield-sapping losses. In collaboration with industry partners, we ran parallel scale-ups using both the racemate and our S-isomer material. The project with our single-isomer product traced more neatly through analytical checkpoints, and the yields showed lower variability—even with equivalent technical experience in both process teams.

We’ve also handled inquiries about in situ synthesis approaches, where some labs consider building the intermediate from simpler starting materials. Our in-house data and partner feedback consistently show the risk of failed syntheses, inconsistent yields, and the introduction of minor contaminants that can derail or prolong development timelines.

With access to robust starting stocks of (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide, project managers can set up reliable workflow timelines, lock in timelines for scale-up, and avoid fire-fighting unexpected delays due to sourcing bottlenecks or underperforming intermediates.

Physical Quality That Matters Day-to-Day

Experience tells us that not all fine chemicals handle the same on the bench. We’ve formulated our batches for clean flow and minimized static pickup, which comes from keeping an eye on particle size and humidity during drying. For teams relying on automated dosing and weighing systems, this means shorter set-up times and fewer system alarms, letting scientists stay focused on actual development work rather than troubleshooting handling issues.

We’ve standardized our packing protocols after getting feedback from analytical groups frustrated with caked or clumped material. The granule size and container selection keep the hydrobromide salt free-flowing yet contained—and every lot leaves sealed with moisture-proof liners to ensure stability until first opening.

Supporting Regulatory and Analytical Requirements

In a field increasingly shaped by compliance, our product undergoes more than standard QC. Each batch arrives with a full analytical panel, including chiral HPLC trace, impurity profiles, remnants of heavy metals if any, moisture analysis, and residual solvent confirmation. Should you need supporting documentation for a regulatory submission or custom analytical markers, our technical staff responds within business hours, with full access to archived batch data going back years.

We appreciate the serious scrutiny facing products that end up in clinical pipelines. Our transparency in process documentation and change notification builds long-term trust with both researchers and organizations upholding high auditing standards. The dialogue and feedback loops we maintain directly strengthen both our quality system and customer outcomes.

Continuous Improvement Driven by Real Needs

Our shop-floor staff, lab technicians, and R&D chemists unite in one physical site. This layout supports rapid communication—from the person setting up a reaction to the one running final packing. Real feedback, whether good or bad, gets addressed the same week it appears. If analytical staff spots a minor drift in purity, root-cause analysis kicks in before the issue becomes a trend—an approach that comes from years of knowing a single failure ripples through multiple projects.

We invest in cross-training not just because audits require it, but because chemists who know the whole process catch mistakes in real-time. Our shifts work in well-lit, climate-controlled spaces, with opportunities to see work from synthesis through packaging. These steady improvements led us to tighten our yield consistency, reduce solvent waste, and improve the documentation supporting every kilogram we release.

What Sets Our Product Apart

It’s not a secret formula or secretive process that sets our (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide apart, but transparent day-to-day decisions. We listen to our customers—from academic principal investigators to process chemists at contract manufacturers—because they’re the ones who feel the impact when a reagent underperforms. Our personal relationships with purchasing managers, researchers, and sometimes entire project teams give us direct insight into the pressures and requirements driving today’s synthetic chemistry work.

Feedback tells us features chemists notice aren’t always on the product label. Easy solubility, stable storage, and smooth handling impact workflow more than any line on a specification sheet. After seeing how minor variations could swallow hours of time or inject uncertainty into a large project, we set clear benchmarks for flow characteristics, hygroscopicity, and shelf-life stability—often going well above standard requirements to smooth the workflow for labs worldwide.

Looking Forward: Our Pledge as a Manufacturer

Markets continue to evolve rapidly, and new uses emerge in both established and exploratory research fields. With new regulatory scrutiny and the pressure to document everything, quality and traceability are no longer just buzzwords. As a company rooted in synthesis, practical QC and batch-level transparency matter to us—not just marketing claims, but verifiable records any customer can access.

Moving ahead, our investment goes into both analytical infrastructure and skilled personnel. Ongoing automation means more lot data gets captured automatically, freeing up skilled chemists for real troubleshooting or development challenges. Expanded capacity lets us keep up when customers scale up projects overnight or request custom variants of existing products.

Most of our growth comes from rapport—earned by standing behind the product. It’s easy to advertise, but much harder to earn ongoing recommendations from working researchers and experienced technical buyers. When a project’s success or failure hangs on a single molecule, our role is to support, deliver, and improve based on actual needs. Our (S)-(-)-Alpha-Amino-Gamma-Butyrolactone Hydrobromide isn’t just a reagent; it’s the result of real collaboration, day by day, with customers who rely on quality results for their science and their business.